Skip to main content

BARCLAYS PLC

Position in CTMX — CytomX Therapeutics, Inc.

CIK 312069 LONDON, X0

Position in CTMX

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$474,055
-$195,280 QoQ
Shares Held
126,415
-11.2% QoQ
Ownership
0.058%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#69
of 178 holders
Holding Since
Mar 2020
15 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in CTMX Over Time

Shares Held

Position Value (USD)

Derivatives in CTMX

reported options exposure · as of Mar 31, 2026
CallValue
$3,290,000
CallShares
700,000
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

BARCLAYS PLC holds $1,706,204,586 across 455 Biotechnology names. CTMX ranks #169 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in CTMX

Export CSV
16 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $474,055 126,415
2026-03-31 $3,290,000 700,000
2026-03-31 $669,335 142,412
2025-12-31 $1,433,595 336,525
2025-09-30 $4,753 1,490
2025-06-30 $4 2
2025-03-31 $1 2
2022-03-31 $28,109 10,528
2021-12-31 $340,900 78,730
2021-09-30 $564,241 110,853
2021-06-30 $802,523 126,781
2021-03-31 $1,061,359 137,304
2020-12-31 $589,591 90,014
2020-09-30 $196,441 29,540
2020-06-30 $288,734 34,662
2020-03-31 $179,224 23,367